p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy
Hardwick, N. R., Frankel, P., Ruel, C., Kilpatrick, J., Tsai, W., Kos, F., Kaltcheva, T., Leong, L., Morgan, R., Chung, V., Tinsley, R., Eng, M., Wilczynski, S., Ellenhorn, J. D. I., Diamond, D. J., Cristea, M.
The American Association for Cancer Research (AACR)
Published 2018
The American Association for Cancer Research (AACR)
Published 2018
Publication Date: |
2018-03-16
|
---|---|
Publisher: |
The American Association for Cancer Research (AACR)
|
Print ISSN: |
1078-0432
|
Electronic ISSN: |
1557-3265
|
Topics: |
Medicine
|
Published by: |